GLOBAL HEALTH LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.115 AUD | 0.00% |
|
0.00% | -4.17% |
| Apr. 25 | Global Health's Nine-Month Revenue Rises 12% | MT |
| Feb. 26 | Global Health Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 6.694 | 4.715 | 8.209 | 23.53 | 13.03 | 7.83 |
| Enterprise Value (EV) 1 | 7.223 | 5.077 | 8.359 | 18.99 | 6.795 | 5.631 |
| P/E ratio | -15.9 x | -3.62 x | -127 x | -41.2 x | -6.28 x | -0.96 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.27 x | 0.86 x | 1.31 x | 3.35 x | 1.99 x | 1 x |
| EV / Revenue | 1.37 x | 0.92 x | 1.34 x | 2.7 x | 1.04 x | 0.72 x |
| EV / EBITDA | -25.1 x | -6.25 x | -71.2 x | 21,604 x | -3.44 x | -1.51 x |
| EV / FCF | -3.01 x | -27.3 x | -11.1 x | 24.8 x | -3.91 x | -2 x |
| FCF Yield | -33.2% | -3.66% | -8.97% | 4.03% | -25.6% | -50.1% |
| Price to Book | 1.47 x | -6.5 x | 30.5 x | 5.82 x | 2.14 x | -4.83 x |
| Nbr of stocks (in thousands) | 33,470 | 33,679 | 42,098 | 49,528 | 56,650 | 58,003 |
| Reference price 2 | 0.2000 | 0.1400 | 0.1950 | 0.4750 | 0.2300 | 0.1350 |
| Announcement Date | 9/30/18 | 9/30/19 | 8/31/20 | 9/30/21 | 8/31/22 | 10/30/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 5.289 | 5.513 | 6.249 | 7.029 | 6.536 | 7.818 |
| EBITDA 1 | -0.2882 | -0.8127 | -0.1174 | 0.000879 | -1.972 | -3.724 |
| EBIT 1 | -0.3518 | -0.8456 | -0.1381 | -0.0115 | -1.976 | -3.729 |
| Operating Margin | -6.65% | -15.34% | -2.21% | -0.16% | -30.23% | -47.7% |
| Earnings before Tax (EBT) 1 | -0.4451 | -0.9717 | -0.2421 | -0.6256 | -2.01 | -7.7 |
| Net income 1 | -0.4212 | -1.297 | -0.0601 | -0.488 | -2.049 | -8.055 |
| Net margin | -7.97% | -23.52% | -0.96% | -6.94% | -31.35% | -103.02% |
| EPS 2 | -0.0126 | -0.0386 | -0.001540 | -0.0115 | -0.0366 | -0.1400 |
| Free Cash Flow 1 | -2.396 | -0.1859 | -0.75 | 0.7656 | -1.736 | -2.822 |
| FCF margin | -45.3% | -3.37% | -12% | 10.89% | -26.57% | -36.1% |
| FCF Conversion (EBITDA) | - | - | - | 87,103.87% | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/30/18 | 9/30/19 | 8/31/20 | 9/30/21 | 8/31/22 | 10/30/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.53 | 0.36 | 0.15 | - | - | - |
| Net Cash position 1 | - | - | - | 4.54 | 6.23 | 2.2 |
| Leverage (Debt/EBITDA) | -1.834 x | -0.445 x | -1.279 x | - | - | - |
| Free Cash Flow 1 | -2.4 | -0.19 | -0.75 | 0.77 | -1.74 | -2.82 |
| ROE (net income / shareholders' equity) | -8.95% | 1,090% | 26.4% | -18.8% | -40.5% | -361% |
| ROA (Net income/ Total Assets) | -1.97% | -8.27% | -1.36% | -0.09% | -12.3% | -32.9% |
| Assets 1 | 21.35 | 15.68 | 4.413 | 531 | 16.7 | 24.45 |
| Book Value Per Share 2 | 0.1400 | -0.0200 | 0.0100 | 0.0800 | 0.1100 | -0.0300 |
| Cash Flow per Share 2 | 0.0300 | 0.0200 | 0.0200 | 0.1000 | 0.1100 | 0.0400 |
| Capex 1 | 0 | - | 0 | - | 0.01 | 0.01 |
| Capex / Sales | 0.01% | - | 0.01% | - | 0.12% | 0.12% |
| Announcement Date | 9/30/18 | 9/30/19 | 8/31/20 | 9/30/21 | 8/31/22 | 10/30/23 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -4.17% | 4.35M | |
| +4.36% | 32.47B | |
| +14.14% | 7.45B | |
| +22.93% | 3.89B | |
| -16.29% | 3.15B | |
| -25.96% | 1.28B | |
| -36.14% | 1.09B | |
| -0.13% | 893M | |
| -35.42% | 902M | |
| -24.12% | 857M |
- Stock Market
- Equities
- GLH Stock
- Financials Global Health Limited
